DEFA14A: Zomedica Corp. Announces Annual Shareholder Meeting to be Held Virtually on June 6, 2024

Zomedica Corp. will hold its annual shareholder meeting virtually on June 6, 2024, to elect directors, ratify the appointment of auditors, and approve executive compensation.

Summary

• Zomedica Corp. will hold its annual meeting of shareholders online on June 6, 2024, at 1:00 p.m. Eastern Daylight Time.
• Shareholders can attend the meeting virtually via live audio webcast.
• Registered shareholders and proxyholders can attend, submit questions, and vote in real time.
• Non-registered shareholders can attend as guests and ask questions but cannot vote unless they have appointed themselves as a proxyholder.
• The meeting will cover the election of eight director nominees, ratification of Grant Thornton LLP as the independent auditor for 2023, and an advisory vote on executive compensation.
• The board of directors recommends voting FOR all director nominees and FOR the ratification of the auditor and the advisory vote on executive compensation.
• Meeting materials, including the annual report on Form 10-K for the year ended December 31, 2023, the circular, and the proxy form, are available online at www.proxyvote.com and sedarplus.ca.
• Shareholders can request a paper copy of the meeting materials free of charge until one year from the date the circular was filed on SEDAR+ by contacting Broadridge before May 21, 2024.
• Shareholders are also entitled to receive Zomedica's interim financial statements and related MD&A and can request them by mail or online.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, indicating a neutral to slightly positive sentiment as it reflects the company's adherence to corporate governance practices.

Positives

• The virtual meeting format allows for broader shareholder participation.
• Shareholders have multiple avenues to access meeting materials (online and paper copies).
• The company encourages electronic delivery of materials to reduce paper waste.

Risks

• Non-registered shareholders who do not follow instructions from their broker may lose their right to vote.
• Technical difficulties could potentially disrupt the virtual meeting.

Future Outlook

The document outlines the agenda and procedures for the upcoming annual meeting, focusing on standard corporate governance matters.

Management Comments

• The directors recommend a vote FOR all nominees under item 1 and FOR items 2 and 3.

Industry Context

The use of a virtual meeting format aligns with current trends in corporate governance, allowing for broader shareholder participation and reduced costs.

Stakeholder Impact

• Shareholders have the opportunity to participate in key decisions regarding the company's governance.
• Employees are indirectly affected by the decisions made at the annual meeting, particularly regarding executive compensation.

Next Steps

• Shareholders should review the meeting materials and vote by proxy before the deadline.
• Shareholders can attend the virtual meeting on June 6, 2024.

Key Dates

Keywords

Annual Meeting, Shareholders, Proxy, Zomedica, Voting, Directors, Auditor, Executive Compensation